Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: (86)Y or (90)Y imaging?

S Walrand, GD Flux, Mark Konijnenberg, R. Valkema, Eric Krenning, R Lhommel, S Pauwels, F Jamar

Research output: Contribution to journalArticleAcademicpeer-review


This paper reviews issues concerning (86)Y positron emission tomography (PET), (90)Y PET and (90)Y bremsstrahlung imaging. Specific methods and corrections developed for quantitative imaging, for application in preclinical and clinical studies, and to assess (90)Y dosimetry are discussed. The potential imaging capabilities with the radioisotopes (87)Y and (88)Y are also considered. Additional studies required to assess specific unaddressed issues are also identified.
Original languageUndefined/Unknown
Pages (from-to)57-68
Number of pages12
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Publication statusPublished - 2011

Research programs

  • EMC MM-01-40-01

Cite this